Use of Health Care Claims Data to Study Patients with Ophthalmologic Conditions

被引:96
作者
Stein, Joshua D. [1 ]
Lum, Flora [2 ]
Lee, Paul P. [1 ]
Rich, William L., III [3 ]
Coleman, Anne L. [2 ,4 ,5 ]
机构
[1] Univ Michigan, WK Kellogg Eye Ctr, Ann Arbor, MI 48109 USA
[2] Amer Acad Ophthalmol, H Dunbar Hoskins Jr MD Ctr Qual Eye Care, San Francisco, CA 94109 USA
[3] Northern Virginia Ophthalmol Associates, Falls Church, VA USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, Jonathan & Karen Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA
关键词
OPEN-ANGLE GLAUCOMA; DIABETIC MACULAR EDEMA; MEDICARE BENEFICIARIES; CATARACT-SURGERY; ADVERSE EVENTS; RESOURCE USE; DEGENERATION; RATES; TRENDS; COSTS;
D O I
10.1016/j.ophtha.2013.11.038
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: To describe what information is or is not included in health care claims data, provide an overview of the main advantages and limitations of performing analyses using health care claims data, and offer general guidance on how to report and interpret findings of ophthalmology-related claims data analyses. Design: Systematic review. Participants: Not applicable. Methods: A literature review and synthesis of methods for claims-based data analyses. Main Outcome Measures: Not applicable. Results: Some advantages of using claims data for analyses include large, diverse sample sizes, longitudinal follow-up, lack of selection bias, and potential for complex, multivariable modeling. The disadvantages include (a) the inherent limitations of claims data, such as incomplete, inaccurate, or missing data, or the lack of specific billing codes for some conditions; and (b) the inability, in some circumstances, to adequately evaluate the appropriateness of care. In general, reports of claims data analyses should include clear descriptions of the following methodological elements: the data source, the inclusion and exclusion criteria, the specific billing codes used, and the potential confounding factors incorporated in the multivariable models. Conclusions: The use of claims data for research is expected to increase with the enhanced availability of data from Medicare and other sources. The use of claims data to evaluate resource use and efficiency and to determine the basis for supplementary payment methods for physicians is anticipated. Thus, it will be increasingly important for eye care providers to use accurate and descriptive codes for billing. Adherence to general guidance on the reporting of claims data analyses, as outlined in this article, is important to enhance the credibility and applicability of findings. Guidance on optimal ways to conduct and report ophthalmology-related investigations using claims data will likely continue to evolve as health services researchers refine the metrics to analyze large administrative data sets. (C) 2014 by the American Academy of Ophthalmology.
引用
收藏
页码:1134 / 1141
页数:8
相关论文
共 42 条
[1]   Age-related macular degeneration is associated with an increased risk of hip fractures in the medicare database [J].
Anastasopoulos, Eleftherios ;
Yu, Fei ;
Coleman, Anne L. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2006, 142 (06) :1081-1083
[2]  
[Anonymous], CURR PROC TERM, V4
[3]   Identification of patients with diabetic macular edema from claims data - A validation study [J].
Bearelly, Srilaxmi ;
Mruthyunjaya, Prithvi ;
Tzeng, Janice P. ;
Suner, Ivan J. ;
Shea, Alisa M. ;
Lee, Jeffrey T. ;
Kowalski, Jonathan W. ;
Curtis, Lesley H. ;
Schulman, Kevin A. ;
Lee, Paul P. .
ARCHIVES OF OPHTHALMOLOGY, 2008, 126 (07) :986-989
[4]   Use of insurance claims databases to evaluate the outcomes of ophthalmic surgery [J].
Coleman, AL ;
Morgenstern, H .
SURVEY OF OPHTHALMOLOGY, 1997, 42 (03) :271-278
[5]   Eye-related medicare costs for patients with age-related macular degeneration from 1995 to 1999 [J].
Coleman, Anne L. ;
Yu, Fei .
OPHTHALMOLOGY, 2008, 115 (01) :18-25
[6]   Use of gonioscopy in Medicare beneficiaries before glaucoma surgery [J].
Coleman, Anne L. ;
Yu, Fei ;
Evans, Stacy J. .
JOURNAL OF GLAUCOMA, 2006, 15 (06) :486-493
[7]   Medicare Costs for Neovascular Age-Related Macular Degeneration, 1994-2007 [J].
Day, Shelley ;
Acquah, Kofi ;
Lee, Paul P. ;
Mruthyunjaya, Prithvi ;
Sloan, Frank A. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2011, 152 (06) :1014-1020
[8]   Clinical quality measurement - Comparing chart review and automated methodologies [J].
Dresser, MVB ;
Feingold, L ;
Rosenkranz, SL ;
Coltin, KL .
MEDICAL CARE, 1997, 35 (06) :539-552
[9]  
Fitch K., 2001, The RAND/UCLA appropriateness method user's manual
[10]   Using pharmacy claims data to study adherence to glaucoma medications: Methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS) [J].
Friedman, David S. ;
Quigley, Harry A. ;
Gelb, Laurie ;
Tan, Jason ;
Margolis, Jay ;
Shah, Sonali N. ;
Kim, Elizabeth E. ;
Zimmerman, Thom ;
Hahn, Steven R. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2007, 48 (11) :5052-5057